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Abstract
Activation of inflammatory immune responses during granuloma formation by the host upon infection of mycobacteria is
one of the crucial steps that is often associated with tissue remodeling and breakdown of the extracellular matrix. In these
complex processes, cyclooxygenase-2 (COX-2) plays a major role in chronic inflammation and matrix metalloproteinase-9
(MMP-9) significantly in tissue remodeling. In this study, we investigated the molecular mechanisms underlying
Phosphatidyl-myo-inositol dimannosides (PIM2), an integral component of the mycobacterial envelope, triggered COX-2
and MMP-9 expression in macrophages. PIM2 triggers the activation of Phosphoinositide-3 Kinase (PI3K) and Notch1
signaling leading to COX-2 and MMP-9 expression in a Toll-like receptor 2 (TLR2)-MyD88 dependent manner. Notch1
signaling perturbations data demonstrate the involvement of the cross-talk with members of PI3K and Mitogen activated
protein kinase pathway. Enforced expression of the cleaved Notch1 in macrophages induces the expression of COX-2 and
MMP-9. PIM2 triggered significant p65 nuclear factor -kB (NF-kB) nuclear translocation that was dependent on activation of
PI3K or Notch1 signaling. Furthermore, COX-2 and MMP-9 expression requires Notch1 mediated recruitment of Suppressor
of Hairless (CSL) and NF-kB to respective promoters. Inhibition of PIM2 induced COX-2 resulted in marked reduction in
MMP-9 expression clearly implicating the role of COX-2 dependent signaling events in driving the MMP-9 expression. Taken
together, these data implicate PI3K and Notch1 signaling as obligatory early proximal signaling events during PIM2 induced
COX-2 and MMP-9 expression in macrophages.
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Introduction
Mycobacterium tuberculosis, the causative agent of pulmonary
tuberculosis, infects one-third of the world’s population [1]. The
granuloma formation represents pathological attributes of the host
immunity to M. tuberculosis infection and is responsible for the
containment of the infection. It has been suggested that the
granuloma formation represents a complex process involving
initiation and development of organized multicellular structures
comprised of macrophages, CD4 and CD8 T cells, dendritic cells
as well as components of extracellular matrix (ECM) [2]. Despite
the well-documented pathological attributes of infection triggered
granuloma formation, molecular details on the granuloma
formation in terms of the role of inflammatory responses with
reference to ECM proteins or lymphocytes trafficking are
inadequately understood. Matrix metalloproteinases (MMPs) are
Zn
2+ and Ca
2+ dependent endopeptidases which participate in a
significant manner in several aspects of host immune responses
such as granuloma formation, matrix remodeling, lymphocytes
trafficking and infiltrations, inflammation etc. Among MMPs,
MMP-9 is expressed at various clinical categories of tuberculosis
disease like active cavitary tuberculosis [3–4], meningitis [5–6] and
pleuritis [7]. In case of pulmonary tuberculosis, breakdown of
ECM forms an integral part of the granuloma formation [8].
Mycobacterial species are known to induce MMP-9 expression
and MMP-9 induction in macrophages is suggested to involve
Cyclooxygenase-2 (COX-2) dependent signaling events [9]. COX-
2 is a key enzyme that catalyzes the rate-limiting step in the
inducible secretion of Prostaglandin E2 (PGE2) [10]. In this
perspective, studies have suggested that MMP-9 expression in
macrophages was induced by Prostaglandin E2, and inhibition of
COX-2 resulted in inhibition of mycobacterium triggered MMP-9
expression [9]. Inhibition of macrophage COX-2 activity resulted
in marked reduction in ECM induced expression of MMP-9 [11].
Further, in COX-2 null macrophages, MMP-9 expression was
markedly reduced in comparison to wild type suggesting the role of
COX-2-MMP-9 axis as significant factor at sites of chronic
inflammation [11–12]. Taken together, COX-2 dependent PGE2
production appears to be an important factor in driving the MMP-
9 expression, a step critical for the breakdown of the ECM
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species of mycobacteria, the mycobacterial antigens are known to
trigger the inducible expression of COX-2 and MMP-9 [9,13–15].
Macrophages are principal mediators of initiation as well as
activation of host inflammatory responses to tuberculosis infection.
Albeit mycobacteria reside within phagolysosomes of the infected
macrophages, envelope glycoconjugates like Lipoarabinomannan
(LAM), phosphatidyl-myo-inositol mannosides (PIM), Trehalose
6,69-dimycolate (TDM; cord factor) etc., are released and traffic
out of the mycobacterial phagosome into endocytic compartments
as well as can gain access to the extracellular environment in the
form of exocytosed vesicles [16–17]. In this perspective, PIM
represents a variety of phosphatidyl-myo-inositol mannosides (PIM)
1–6 containing molecules and are integral component of the
mycobacterial envelope. A number of biological functions have
been credited to PIM2 [18,19–24]. PIM2 was shown to trigger
TLR2 mediated activation of macrophages that resulted in
activation of nuclear factor– kB (NF-kB), AP-1, and mitogen-
activated protein kinases (MAPK) [25]. In addition to pulmonary
granuloma-forming activities, PIM2 was shown to recruit NKT
cells into granulomas [26]. Further, PIM was suggested to act as
adhesins mediating attachment of M. tuberculosis bacilli to non-
phagocytic cells [27]. Accordingly, mycobacterial envelope antigen
PIM2 could initiate or affect the inflammatory responses similar to
mycobacteria bacilli.
In the present study, we set out to delineate the signaling
cascades regulating PIM2 triggered expression of MMP-9 and
COX-2 in macrophages. Albeit MAPK and NF-kB signaling
pathways are generally believed to be involved [28–30], little is
known about the signaling molecules playing significant roles
upstream of MAPK and NF-kB during mycobacterial antigens
induced COX-2 and MMP-9 expression. Our current study
provides the evidence that PIM2 driven activation of Notch and
Phosphoinositide 3-kinase (PI3K) signaling cascades triggers the
expression of COX-2 and MMP-9.
Among diverse signaling cascades, Notch signaling pathway is
suggested to execute important function during initiation or
activation of inflammatory immune responses [31]. In general,
productive interaction of Notch receptor with its ligand causes the
proteolytic cleavage mediated by gamma-secretase complex to
release Notch Intra Cellular Domain (cleaved Notch or NICD).
NICD then translocates to the nucleus and collaborate with DNA
binding protein CSL/RBP-Jk along with coactivators leading to
the transcription of its target genes [32]. On the other hand, it has
been demonstrated that NICD can regulate the expression of
many of its target genes in a transcription-independent manner by
activating PI3K and MAPK signaling cascades [33–34]. The
PI3K-AKT signaling cascade regulates and modulates several
cellular processes including cell survival, proliferation, growth etc.
[35]. Additionally, survival effects of Notch signaling are reported
to be mediated by activation of the MAPK in many tumors and
the regulation of PI3K-AKT-MAPK axis could offer a mechanis-
tic basis for Notch signaling in the promotion of primary tumor
progression [32].
TLR stimulation by various agonists was shown to activate
Notch signaling resulting in modulation of diverse target genes
involved in pro-inflammatory responses in macrophages [13,36–
37]. Further, we demonstrated previously that M. bovis BCG
induced expression of SOCS3 involved Notch1 upregulation and
activation of Notch1 signaling pathway in a TLR2-MyD88
manner [36]. However, possible implications of Notch signaling
on immunological parameters associated with interaction of host
macrophages with intracellular pathogen like mycobacteria or its
novel cell wall antigens remain scanty.
In this study, we show that PIM2 triggered COX-2 and MMP-9
expression requires the involvement of PI3K and Notch1 signaling
and distinctly, perturbation of Notch1 signaling suggests involve-
ment of the cross-talk with members of PI3K and MAP kinase
pathway. These data establish a role for PI3K and Notch1
signaling in PIM2 induced COX-2 and MMP-9 expression in
macrophages.
Results
PIM2 induces COX-2 and MMP-9 expression in
macrophages
In this study, we examined the molecular details of PIM2
induced signaling events that are leading to the expression of
COX-2 and MMP-9. PIM2 treatment of mouse peritoneal
macrophages triggers the expression of COX-2 and MMP-9 both
at mRNA and protein levels (Figure 1A–B). PIM2 triggered
expression of both COX-2 and MMP-9 transcripts as early as
2 hours, clearly peaking in their expression at 12 hrs (Figure S1A).
Accordingly, PIM2 induced COX-2 and MMP-9 protein
expression could be detected as early as 2 hours (faint band) up
to 16 hours of the post-PIM2 treatment (Figure 1B). Further, in
addition to the release of MMP-9 in the medium, experiments
were carried out to explore whether PIM2 increases the cell
membrane associated MMP-9 by flow cytometry. PIM2 treatment
increased the percentage of cells that were stained positive for
membrane MMP-9 compared to untreated cells (Figure 1C).
Confocal microscopy studies further validated PIM2 triggered
increased cell-surface association of MMP-9, where in macrophages
were stained for nucleus (with nuclear staining dye, Hoechst 33342,
blue), plasma membrane (with anti-MHC Class I antibody, red) and
for MMP-9 (with anti-MMP-9 antibody, green). The merged images
from confocal microscopic analysis revealed that MMP-9 or MHC
class I do not colocalize clearly demonstrating a distinct cell-surface
associationofMMP-9(Figure1Dand FigureS1B).COX-2isknown
to regulate mycobacteria triggered MMP-9 expression and accord-
ingly, when tested, COX-2 inhibitor NS-398 markedly blocked
MMP-9 expression both at RNA (Figure S2A) and protein levels
clearly implicating the role COX-2 dependent signaling events in
PIM2 induced MMP-9 expression (Figure S2B). In order to further
ascertain the specific effect of NS-398, we analyzed the cell-surface
expression of MMP-9 upon PIM2 treatment in the presence or
absence of NS-398. Flow cytometry results presented in Figure 1E
demonstrate that blocking COX-2 activity by NS-398 significantly
reduced PIM2 triggered surface MMP-9 expression. Further,
purified PGE2 increased MMP-9 expression in a dose dependent
manner in mouse macrophages (Figure S3). In order to exclude the
autocrine or secondary effect of macrophage produced cytokines on
PIM2 triggered COX-2 and MMP-9 expression, mouse macro-
phages were treated with PIM2 in the presence or absence of
cycloheximide. The data presented clearly demonstrates that PIM2
triggered COX-2 and MMP-9 mRNA expression was not affected
by cycloheximide clearly ruling out the autocrine effect of PIM2
induced cytokines on COX-2 and MMP-9 expression (Figure S4A–
B). However, interestingly, cycloheximide augmented PIM2 trig-
gered COX-2 mRNA expression. Extensive literature survey
suggests that the regulation of COX-2 gene is complex and
transcription of COX-2 is reported to vary across the cell types as
well as among responses of a given cell type to variety of stimuli [54–
56]. This effect has been attributed to the presence of AU-rich
elements in 39-untranslated region of COX-2 mRNA, which is
suggested to be an important determinant in COX-2 mRNA
stability in human macrophages [55] as well as in diverse cell types
[54].
PIM2 Induces COX-2 and MMP-9
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Mycobacteria are known to trigger the activation of intracellular
signalling pathways [38], such as PI3K and MAPK including
extracellular signal-regulated kinase (ERK) 1/2, p38 kinase as well
as stress-activated protein kinase/c-Jun NH2-terminal kinase
(SAPK/JNK). In view of published observations [38], attempts
were made in the current investigation to elucidate the role of
PI3K and MAPK in PIM2 triggered expression of COX-2 and
MMP-9. We used pharmacological inhibitors of PI3K, AKT and
MAPK to test the functional involvement of the PI3K or MAPK
signaling in PIM2 treated macrophages. In this context, Figure 2A
clearly demonstrates that inhibitors of PI3K, LY294002 or AKT
inhibitor, clearly reversed PIM2 triggered COX-2 and MMP-9
expression. Additionally, AKT inhibitor markedly decreased
PIM2 induced surface expression of MMP-9 as well as COX-2
protein levels (Figure 2B and data not shown). In addition, PI3K
inhibitor, LY294002, abrogated PIM2 triggered cell-surface
expression of MMP-9 (Figure S5). Further, PIM2 triggered
phosphorylation of AKT and 4EBP1 (Figure 2C) clearly
demonstrating the activation of PI3K pathway. Perturbation of
PI3K signaling cascade by siRNA to AKT (Figure S8A) resulted in
striking reduction in COX-2 and MMP-9 expression (40% and
81% decrease for COX-2 and MMP-9 to actin protein ratio
respectively, Figure 2D). Further, AKT dominant negative
construct effectively blocked PIM2 ability to induce COX-2
(Figure 2E) and MMP-9 expression (Figure 2F).
In order to further delineate the signaling events, peritoneal
macrophages were treated with LY294002, a PI3K inhibitor
before PIM2 treatment. The inhibitor LY294002 significantly
reduced PIM2 activated 4EBP1 phosphorylation (Figure 2G).
During this stage of current investigation, experimental results
obtained in parallel suggested the involvement of Notch1 signaling
in PIM2 induced COX-2 and MMP-9 expression. These results
are presented in detail in Figure 3 of this manuscript. Since it has
been suggested that PI3K-AKT pathway can operate in concert as
a gain control for Notch signal responses in many cell types,
attempts were carried out to assess whether Notch activation
inhibitor, c-secretase inhibitor-I (GSI-I) could abrogate PIM2
triggered phopshorylation of AKT, mTOR, and 4EBP1. GSI-I,
when tested, significantly blocked PIM2 triggered AKT, mTOR
and 4EBP1 (Figure S6 and Figure 2G). These findings implicate
possible cross-talks between PI3K and Notch signaling cascades
during PIM2 induced expression of COX-2 and MMP-9.
PIM2 mediated activation of PI3K signaling involves
Notch activation
As described, many studies have suggested that PI3 kinase and
MAPK pathways induced survival effects in many cell types often
involve Notch1 signaling [32–34]. In this regard, experiments
were carried out to assess whether PIM2 can trigger Notch
expression and as represented in Figure 3A, PIM2 induced the
upregulation of Notch1, both at mRNA and at protein levels as
quantified by real-time PCR and western blot analysis respectively
(data not shown). Further, PIM2 treatment enhanced the
expression of Notch ligands, Jagged and Delta as well as
expression of different members of Notch family like Fringes,
Presinilin and Kuzbanian (Figure S7 and data not shown).
Additionally, immunoblotting experiments demonstrated a similar
Figure 1. PIM2 induces expression of COX-2 and MMP-9 in mouse peritoneal macrophages. (A). Mouse peritoneal macrophages were
treated with 0.5 and 4.0 mg/ml of PIM2 and mRNA levels of COX-2 and MMP-9 were analyzed by Quantitative real time PCR. (B). The levels of COX-2
and MMP-9 protein expression were evaluated by immunoblotting in total cell lysates prepared from macrophages treated with 4.0 mg/ml of PIM2 for
different time points. (C). Flow cytometric analysis of MMP-9 expression on the surface of PIM2 treated macrophages. Cells were probed with anti-
MMP-9 or isotype matched control antibody followed by anti- rabbit FITC. (D). Immunoflourescent staining of MMP-9 on macrophages treated with
4.0 mg/ml of PIM2 as analyzed by confocal microscopy. Cells were fixed and MMP-9 expression was detected by binding of specific or isotype
matched antibodies followed by probing with Cy-2 (green) labeled anti-rabbit secondary antibody. Nucleus of macrophages were stained with
nuclear staining dye, Hoechst 33342 (blue) and plasma membrane with anti-MHC Class I antibody-Cy5 (red). (E). Mouse macrophages were cultured
with or with out NS-398 (10 mM) and treated with 4.0 mg/ml of PIM2 for 12 h. The protein levels of MMP-9 were analyzed by immunoflourescent
staining of MMP-9 followed by flow cytometry. The data represented in the figure are representative of three independent experiments. Med,
Medium.
doi:10.1371/journal.pone.0004911.g001
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cleavage product of Notch1 as well as full-length Notch1 in
macrophages upon treatment with PIM2 (Figure 3B and data not
shown). Further in agreement with Notch activation, the Notch1
target gene Hes1 [32] was also induced by PIM2 treatment
(Figure 3C). Furthermore, we generated RAW 264.7 stable
transfectants constitutively expressing Notch1 intracellular domain
(RAW-NICD). The constitutively active NICD protein induced
COX-2 and MMP-9 expression as well as the expression of Notch
target gene, Hes1 (Figure 3D and data not shown). In addition,
PIM2 further augmented ability of constitutively active NICD to
induce COX-2 and MMP-9 expression (data not shown). These
results evidently strengthen the role of possible crosstalk between
PI3K and Notch signaling during PIM2 induced expression of
COX-2 and MMP-9.
In order to further validate the involvement of upregulated
Notch1 or NICD, chemical inhibitors that affect the Notch
processing were tested for their effect on COX-2 and MMP-9
expression. As shown in Figure 3E–F, GSI-I, c-secretase inhibitor
blocked PIM2 triggered COX-2 and MMP-9 expression. In
addition to GSI-I, the PI3K inhibitor, LY294002 markedly
inhibited PIM2 triggered cell-surface associated MMP-9 as well
as secreted form of MMP-9 (Figure 3F, Figure S5 and data not
shown) implicating the role of both Notch and PI3K signaling in
PIM2 triggered signaling events. In these experiments, treatment
with the GSI-I resulted in a loss of processed Notch1-NICD (data
not shown), which preceded the induction of COX-2 and MMP-9
expression. This was accompanied by a minimal change if any in
expression of total Notch1 (data not shown). Further, siRNA
mediated inhibition of Notch1 signaling (Figure S8B) resulted in
Figure 2. PIM2 induced upregulation of COX-2 and MMP-9 requires Notch1 mediated activation of PI3 Kinase pathway. (A). COX-2
and MMP-9 transcript levels were analyzed in mouse macrophages pretreated with LY294002 (50 mM), AKT inhibitor II (10 mM) or 0.1% DMSO as
vehicle control and then cultured in the presence of PIM2 (4.0 mg/ml) for 12 h. (B). MMP-9 at the cell surface was analyzed by flow cytometry on PIM2
treated macrophages cultured with or without AKT inhibitor II (10 mM) or 0.1% DMSO as vehicle control. (C). Kinetics of phosphorylation of AKT and
4EBP1 upon treatment of PIM2. The blots were stripped and probed for total levels of AKT and 4EBP1 as control. (D). RAW 264.7 macrophages were
transiently transfected with either control siRNA or AKT siRNA. After three days of transfection, cells were treated with PIM2 and protein levels of AKT
as well as COX-2 and MMP-9 were analyzed. The blots from three independent experiments were densitometrically quantitated and represented as
fold change over medium. (E). RAW 264.7 macrophages were transfected with either empty vector or dominant-negative AKT (AKT-DN) followed by
treatment with PIM2. Transcript levels of COX-2 were analyzed by quantitative real-time PCR and (F). Surface expression of MMP-9 was analyzed by
flow cytometry using rabbit anti-MMP-9 antibody followed by probing with Cy-2 labeled anti-rabbit secondary antibody. (G). Mouse macrophages
were pretreated with LY294002 (50 mM) or GSI-I (10 mM) and activation of 4EBP1 at 30 and 60 min post treatment of PIM2 was analyzed. Histogram
represents densitometric analysis of phospho-4EBP1 normalized against total 4EBP1 derived from three independent experiments. The results shown
represent three independent experiments. Med, Medium.
doi:10.1371/journal.pone.0004911.g002
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Evidence in the literature suggests that multiple effects of Notch
signaling often require both transcription-dependent and tran-
scription-independent processes [32,39]. In this perspective, a
potential role of CSL/RBP-Jk in Notch1 induced expression of
COX-2 and MMP-9 was investigated. The activation of Notch
target genes often involves interaction of NICD with DNA binding
protein, CSL/RBP-Jk. In order to address the effect of Notch1
signaling on CSL/RBP-Jk activation, RAW 264.7 macrophages
were transfected with Hes1-Luc, followed by treatment with PIM2
either in the presence or absence of GSI-I, a Notch1 activation
inhibitor. The data presented in Figure S9 demonstrates that the
inhibition of Notch1 signaling significantly blocks the CSL/RBP-
Jk dependent activation of Notch target gene, Hes1 gene
transcription. Further, the downregulation of CSL/RBP-Jk by
siRNA (Figure S8C) in PIM2 treated macrophages resulted in
significant decrease in COX-2 and MMP-9 expression (97% and
87% decrease in COX-2 and MMP-9 to actin protein ratio
respectively, Figure 3G). This result clearly suggests that Notch
signaling regulates COX-2 and MMP-9 expression to a significant
extent in a transcription-dependent manner.
Further, in addition to siRNA and pharmacological inhibition
of Notch1 signaling, we have made use of soluble form of Jagged1,
a known Notch1 ligand, to inhibit PIM2 triggered Notch1
signaling. Many studies have reported that, when expressed,
extracellular soluble form of Jagged1 exerts dominant-negative
effect on Notch signaling possibly by sequestering the Notch
receptor and preventing Notch interaction with its ligands [40–
42]. In this perspective, soluble Jagged1 markedly reduced not
only PIM2 triggered cleaved Notch1 (NICD) formation
(Figure 4A), but also the subsequent expression of COX-2 and
MMP-9 in macrophages (Figure 4B–C).
Figure 3. PIM2 induced expression and activation of Notch1 is involved in induced expression of COX-2 and MMP-9 in
macrophages. (A). Real-time PCR quantification of Notch1 mRNA expression levels in mouse macrophages after treatment with 4.0 mg/ml of PIM2
for 12 h (B). Kinetics of protein expression of Cleaved Notch1 was analyzed in mouse macrophages treated with 4.0 mg/ml of PIM2 for the indicated
time points. (C). Hes1 transcript levels were assessed by real time PCR in mouse macrophages after treatment with 4.0 mg/ml of PIM2 for 12 h. (D).
RAW 264.7 macrophages stably transfected with pCMV-NICD, Notch intracellular domain, (RAW-NICD) or vector pCMV (RAW-Vec) were analyzed for
the expression of NICD, COX-2, MMP-9 and b-actin as loading control. (E). PIM2 (4.0 mg/ml) treated macrophages were cultured with or with out c-
secretase inhibitor GSI-I (10 mM) and the levels of COX-2 and MMP-9 transcript (at 12 h) were analyzed by quantitative real time PCR. (F).
Macrophages were treated with 4.0 mg/ml of PIM2 for 12 h cultured in the presence of LY294002 (50 mM), GSI-I (10 mM) or 0.1% DMSO and cell
surface expression of MMP-9 was analyzed by flow cytometry. (G). RAW 264.7 macrophages were transfected with 100 nM of small interfering RNA
(siRNA) directed to either Notch1 or RBP-Jk siRNA or control siRNA. Three days post transfection, cells were treated with PIM2 for 12 h and protein
levels of COX-2 as well as MMP-9 were analyzed. The blots from three independent experiments were quantitated by densitometry and represented
as fold change over medium. The results are expressed as mean6SEM of three independent experiments and the blots are representative of three
independent experiments. Med, Medium.
doi:10.1371/journal.pone.0004911.g003
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PLoS ONE | www.plosone.org 5 March 2009 | Volume 4 | Issue 3 | e4911Involvement of TLR2 in PIM2 triggered Notch1 signaling
Studies have suggested that mycobacteria induced the expres-
sion of COX-2 or MMP-9 required the involvement of TLR2 [9]
and PIM2 triggered secretion of proinflammatory stimuli such as
TNF-a and IL-12 in a TLR2 dependent manner in murine and
human macrophages [24]. In this context, when assessed, TLR2
dominant-negative construct significantly reduced PIM2 triggered
MMP-9 expression (Figure 5A) clearly implicating the role of
TLR2 in PIM2 mediated activation of signaling events in
macrophages. Further, siRNA mediated downregulation of
MyD88 expression; a downstream adaptor molecule among
majority of TLR signaling pathways, resulted in substantial
reduction in PIM2 induced MMP-9 expression (Figure S10).
In order to further ascertain the role of TLR2 pathway in
Notch1 activation, RAW264.7 macrophages were either trans-
fected with siRNA targeted to MyD88 or with control siRNA
followed by PIM2 treatment. The data presented in Figure 5B
clearly demonstrates that knockdown of MyD88, a downstream
adaptor molecule in TLR signaling pathways, resulted in the
inhibition of the expression and nuclear localization of NICD.
Further, MyD88 siRNA, but not control siRNA blocked the
nuclear expression of Hes1 (Figure 5C), a marker gene for Notch1
activation. In order to assess localization of NICD or Hes1 in
nucleus, a series of images at an interval of 0.37-mm focal planes
were collected into a z-stack. Every single layer of z-stack was
subjected to image analysis by LSM 5 image examiner software to
visualize and locate NICD/Hes1 protein expression in the
nucleus. Figure S11A demonstrates PIM2 triggered translocation
of NICD (green) or Hes1 (green) into nucleus (red). The truly
colocalized areas/spots exhibited a yellow color (the non-
overlapping spots were either red or green). In addition, scatter
plot were also created using software Combi-FCS LCM META,
which were utilized for obtaining correlation coefficient, a measure
of the strength relationship between the two signals as well as a
measure of how well two signals are correlated (Figure S11B–C).
Additionally, inhibition of TLR2 signaling by TLR2 dominant-
negative construct resulted in substantial reduction in Hes1-
promoter activity (Figure 5D). These data are in complete
agreement with the published studies where in TLR2-mediated
Notch1 up-regulation relied completely on the MyD88 adaptor
protein and TLR2 but not TLR4-mediated, Notch1 up-regulation
was completely abrogated in MyD88
2/2 macrophages [37].
PIM2 triggered COX-2 and MMP-9 expression involves
activation of ERK1/2
Consistent with signaling events reported in many cell types,
Mycobacteria triggered PI3K signaling frequently reported to
involve activation of other intracellular signaling cascades such as
MAPK [38]. In this context, we were interested in assessing
whether PIM2 triggers activation of MAPK, in addition to PI3K
and Notch signaling. Hence, when tested, only U0126 (ERK1/2
inhibitor), but not SB203580 (p38 MAPK inhibitor) or SP600125
(JNK inhibitor) reduced PIM2 triggered COX-2 and MMP-9
expression (Figure 6A). In addition, Ras activation inhibitor,
Manumycin clearly abrogated PIM2 induced COX-2 and MMP-9
expression (Figure 6A–B). Furthermore, exposure of mouse
peritoneal macrophages to PIM2 resulted in an increase in the
phosphorylation of Raf-1, one of the target proteins for Ras, and
Figure 4. Soluble Jagged 1 significantly inhibits PIM2 triggered cleaved Notch1 (NICD), COX-2 or MMP-9 expression. (A). Cleaved
Notch1 levels were assessed in RAW 264.7 macrophages transfected either with soluble Jagged1 construct or Vector construct followed by treatment
with PIM2. (B). As described in (A), in soluble Jagged1 construct transfected cells, transcript levels of COX-2 were analyzed by quantitative real-time
PCR and (C). surface expression of MMP-9 by flow cytometry. The results presented are representative of three independent experiments. Med,
Medium.
doi:10.1371/journal.pone.0004911.g004
PIM2 Induces COX-2 and MMP-9
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macrophages (Figure 6C). However, the COX-2 or MMP-9
expression level remained unperturbed when PIM2 triggered
activation of p38 was inhibited (Figure 6A). Further, in order to
delineate whether activation of ERK1/2 or Raf-1 by PIM2
involves PI3 Kinase or Notch1 signaling, the phospshorylation of
ERK1/2 or Raf-1 by PIM2 was assessed in the presence of
LY294002, an inhibitor of PI3K or GSI-I, c-secretase inhibitor.
PIM2 triggered activation of ERK1/2 or Raf-1 was markedly
reduced, when PI3K signaling or activation of Notch was inhibited
(Figure 6D). These results suggest that ERK1/2 represents as
important mediator in the Notch1-PI3K signaling pathway by
which PIM2 induces COX-2 and MMP-9 expression. Further,
MyD88 is a known critical downstream adaptor molecule in TLR
signaling and siRNA to MyD88 reduces Notch 1 signaling and
PIM2 triggered MMP-9 expression (Figure 5B–C and Figure S10).
In this context, we analyzed the effect of siRNA to MyD88 on
PIM2 triggered ERK1/2 activation. As presented in Figure S12,
siRNA to MyD88 abrogated PIM2 induced activation of ERK1/2
suggesting TLR2-MyD88 dependent PI3K-AKT-MAPK axis
could be the basis for Notch signaling.
In order to further ascertain PIM2 ability to trigger Notch1 or
COX-2 or MMP-9 expression, we attempted to inhibit PIM2
synthesis in M. bovis BCG by D-mannosamine, an inhibitor of PIM
biosynthesis. Biochemical and genetic characterization of the
pimB gene from M. tuberculosis have suggested that PimB is the
a-D-mannose-a(1R6)-phosphatidyl-myo-inositol monomannoside
transferase responsible for the formation of triacyl-PIM2 from
GDP-Man and triacyl-PIM1. In this regard, investigators have
extensively utilized D-mannosamine, an inhibitor of PIM
biosynthesis, as a tool, to identify a-mannosyltransferases involved
in PIM biosynthesis [43–44]. In this regard, when tested, blocking
PIM2 synthesis in M. bovis BCG markedly reduced not only the
formation of cleaved Notch1 (NICD), but also nuclear transloca-
tion of NICD in macrophages (Figure 13A & data not shown).
Importantly, D-mannosamine treated M. bovis BCG fails to trigger
Figure 5. TLR2-MyD88 axis plays important role in PIM2 triggered Notch1 activation. (A). TLR2 dominant-negative construct significantly
reduced PIM2 triggered MMP-9 expression as assayed by MMP-9 luciferase reporter activity as described in Materials and Methods. (B). siRNA
mediated downregulation of MyD88 in PIM2 triggered nuclear localization of NICD as well as (C). in expression of Notch1 target gene, Hes1, as
analyzed by confocal microscopy. (D). RAW 264.7 macrophages were transfected with either vector or dominant-negative TLR2 (TLR2-DN) and Hes1-
Luc, followed by treatment with PIM2. The Hes1 promoter activity was evaluated by Luciferase assay. Data presented in the figure is representative of
three independent experiments. Med, Medium.
doi:10.1371/journal.pone.0004911.g005
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well as the induced expression of COX-2 and MMP-9 (data not
shown & Figure S13A–B). Even though, D-mannosamine did not
affect the cell-viability or the overall colony morphology of the
treated M. bovis BCG (data not shown), experiments were carried
out to assess the cell wall composition of D-mannosamine treated
M. bovis BCG in order to validate the above-mentioned results.
Data presented in Figure S13C clearly demonstrates that
treatment of M. bovis BCG with D-mannosamine resulted in
marked reduction in PIM2 presence in M. bovis BCG, which in our
opinion ascertains above-mentioned results.
Involvement of NF-kB in PIM2 triggered COX-2 and MMP-
9 expression
PI3K or Notch1 mediated activation of its target genes involves
the active recruitment of transcription factor NF-kB [45–46].
Further, the promoters of COX-2 and MMP-9 are found to
contain many cis-acting elements among which, NF-kB have been
implicated in the regulation of both COX-2 and MMP-9 gene
expression. In this context, PIM2 triggered significant p65 NF-kB
translocation from the cytosol to the nucleus which peaked at 15–
60 min and then decreased at 120 min of treatment (Figure 6E
and data not shown). However these treatments did not alter the
total PCNA (nucleus) or b-actin (cytosol) protein levels in the cells
(Figure 6E). Additionally, with regard to cell fractionation studies,
assessment of purity of the nuclear fraction was carried out using
marker protein proliferating cell nuclear antigen (PCNA). In this
context, the cytosol fractions were routinely checked for the
presence of PCNA by immunoblotting to exclude the possibility of
nuclear fraction contamination. PIM2 induced nuclear transloca-
tion of NF-kB was further confirmed utilizing the antibody specific
for the phospho-p65 subunit of NF-kB (Figure S14).
The nuclear translocation of NF-kB, as shown in Figure 6E–F,
is dependent on activation of Notch, as treatment with GSI-I, c-
secretase inhibitor, significantly reduced the nuclear translocation
of NF-kB upon PIM2 treatment. Further, inhibitors of PI3K,
Figure 6. PIM2 induced activation of ERK1/2 and NF-kB is dependent on Notch1 mediated activation of PI3 kinase pathway. (A).
Mouse macrophages were treated with U0126 (10 mM), SB203580 (20 mM), SP600125 (50 mM), Manumycin (20 mM) or DMSO as vehicle control, prior
to treatment with PIM2 for 12 h and COX-2 and MMP-9 mRNA expression levels were analyzed by real time PCR. (B). MMP-9 levels on the cell surface
were assessed by flow cytometry on PIM2 treated macrophages pretreated with Manumycin (20 mM), U0126 (10 mM) or DMSO. (C). Time dependent
activation of Raf-1 and ERK1/2 upon treatment macrophages with 4.0 mg/ml of PIM2. (D). Mouse peritoneal macrophages were pretreated with
LY294002 (50 mM) or GSI-I (10 mM) and phosphorylation status of Raf-1 and ERK1/2 at indicated time points after treatment with PIM2 was assessed.
(E). Mouse macrophages were treated with PIM2 for indicated time points and were fractionated into cytosolic, nuclear fractions and probed for NF-
kB by immunoblotting. (F). Nuclear translocation of NF-kB upon treatment of macrophages with PIM2. Macrophages were treated with U0126
(10 mM), LY294002 (50 mM), GSI-I (10 mM) prior to PIM2 treatment. The graphs show the average of three independent experiments6SEM.
Representative blots from three independent experiments are shown. Med, Medium.
doi:10.1371/journal.pone.0004911.g006
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translocation of NF-kB from cytosol (Figure 6F). In addition, an
IkappaB phosphorylation inhibitor, BAY 11-7082 markedly
diminished PIM2 induced MMP-9 and COX-2 protein levels
(data not shown).
PIM2 increases cell membrane association of MMP-9 via
its interaction to CD44
Many studies have suggested that MMP-9 associates with the
cell membrane and the binding of MMP-9 is suggested to be
mediated by several proteins including CD44 [47]. In this context,
PIM2 increases the expression of cell surface associated MMP-9 as
well as CD44 (Figure 1C and Figure 7A). PIM2 triggered cell
surface CD44 expression can be blocked by inhibitors of PI3K
(LY294002) or by Notch activation inhibitor, GSI-1 (Figure 7B).
Further, for localization studies, double immunofluorescence
experiments were carried out on PIM2 treated non-permeabilized
macrophages (Figure 7C). The MMP-9 protein expression is
indicated by green color and the red color indicates CD44 protein
staining. The merged images from confocal laser scanning
microscopic analysis revealed orange-yellow color shift indicating
the co-localization of MMP-9 and CD44 proteins at the cell
surface. The unstimulated cells exhibited weak signals of MMP-9
expression when stained either with isotypic or anti-MMP-9
antibody.
Discussion
Activation of inflammatory immune responses by the host upon
infection of pathogenic microbes is one of the crucial steps not only
in controlling the spread of pathogen from the site of infection to
reminder of host organs, but also in mounting an effective memory
response so that future exposures/infections by similar pathogen/s
can be effectively controlled. In this context, inflammatory
responses during formation of granuloma in which mycobacteria
resides is often associated with tissue remodeling and breakdown of
the extracellular matrix. In these complex processes, both COX-2
and MMP-9 play a major role in chronic inflammation in general
and MMP-9 significantly in tissue remodeling. Matrix metallo-
proteinases in general can degrade most of the components of
ECM and among MMP’s, MMP-9 is suggested to have important
role in the pathogenesis of the tuberculosis disease [4–8]. During
mycobacteria infection, MMP-9 induction has been implicated in
cells recruitment, representing as an obligatory step in the
formation of granuloma. However, MMP-9 expression can act
as causative for the loss of the structural integrity of the lung tissues
during chronic inflammation [8]. For an example, in case of
Figure 7. Association of PIM2 triggered cell surface MMP-9 associates with CD44. (A). Mouse macrophages were treated with PIM2 for
12 h and cell surface levels of CD44 were analyzed by probing with anti-CD44 or isotype matched control antibody followed by Cy5-conjugated goat
anti- rat IgG. (B). CD44 levels on the cell surface were assessed by flow cytometry on PIM2 treated macrophages pretreated with LY294002 (50 mM) or
GSI-I (10 mM). (C). Surface expression of MMP-9 and CD44 were evaluated by immunofluorescent staining using confocal microscopy. After 12 h
treatment with PIM2, macrophages were probed with anti MMP-9 followed by anti rabbit IgG-Cy-2(green) as well as anti CD44 followed by anti- rat
IgG-Cy5 (red). Merged image shows the areas of colocalization in yellow. The results are representative of three independent experiments. Med,
Medium.
doi:10.1371/journal.pone.0004911.g007
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tissue destruction, a pathological hallmark of inflammatory host
immune response [4–5]. Further, evidences suggest that COX-2
dependent PGE2 regulates macrophage MMP-9 expression and
COX-2 expression is induced in response to a variety of
inflammatory mediators [12].
The current study attempts to delineate the signaling events that
are involved in PIM2 mediated expression of COX-2 and MMP-
9. We show that PIM2, an integral component of the
mycobacterial envelope, induces the expression of MMP-9 as well
as COX-2 in macrophages. We present the evidence that PIM2
triggered expression of COX-2 and MMP-9 involves the
activation of PI3K and Notch1 signaling. Perturbation of Notch1
signaling by siRNA to Notch1 or pharmacological inhibition of
Notch1 signaling or soluble form of Jagged1, which is suggested to
exert dominant-negative effect on Notch1 activation [40–42],
markedly inhibited PIM2 triggered Notch1 signaling as well as
COX-2 and MMP-9 expression (Figure 3–4). Additionally,
inhibition of COX-2 expression results in marked reduction in
PIM2 triggered MMP-9 induction (Figure 1) clearly implicating
the suggested role of COX-2 dependent signaling events in driving
the MMP-9 expression [9]. In addition, enforced expression of the
Notch1 intracellular domain (NICD) in RAW 264.7 macrophages
induces the expression of both COX-2 and MMP-9 (Figure 3).
Overall, our studies suggest that PI3K and Notch1 signaling
contributes as an obligatory early proximal signaling event during
PIM2 induced COX-2 and MMP-9 expression in macrophages. It
is well known that TLRs significantly participate in wide variety of
immune responses and are suggested to play pivotal role in the
activation of inflammatory immune responses by mycobacteria. In
this context, knockdown of MyD88, a downstream adaptor
molecule in TLR signaling pathways resulted in inhibition of the
expression and nuclear localization of Notch1 as well as nuclear
expression of Hes1, a marker gene for Notch1 activation (Figure 5).
The perturbation of TLR2 signaling by TLR2 dominant-negative
construct also resulted in substantial reduction in Hes1 promoter
activity (Figure 5). Additionally, our recent findings suggest that M.
bovis BCG whole bacilli upregulates Notch1 and activates Notch1
signaling pathway in a TLR2-MyD88 dependent manner [36].
Our report clearly suggested that TLR2 can physically associate
with both PI3K and Notch1, which implicates TLR2 triggering by
M. bovis BCG in the activation of PI3K and Notch1. In this
context, while PIM2 is suggested to stimulate murine and human
macrophages in a TLR2 dependent manner [24], it is possible that
PIM2 might trigger Notch1 signaling by interaction with TLR2.
However, further investigations are required to expand the
understanding of the above finding.
As mentioned in the introduction, the involvement of cross-talk
between Notch and PI3K-AKT signaling cascades have been
attributed to the overall cellular responses in diverse sets of cell
types including CHO cells, primary T-cells and hippocampal
neurons [48]. In addition, data suggesting the physical association
of Notch1 with p56lck and PI3K in primary T cells as well as
Notch mediated activation of the MAPK in many tumors suggest
that regulation of PI3K-AKT -MAPK axis may be important
component for Notch signaling [33]. In addition, transformation
of many tumors by Notch requires active signals from the ERK/
MAP kinase and PI3 kinase pathways along with Ras pathway
[49]. Overall, these reports have suggested involvement of PI3K-
AKT, ERK 1/2, and NF-kB, as possible downstream regulators of
Notch signaling. In agreement with these reported findings, the
inhibition of Notch1 or PI3K signaling resulted in significant
decrease in phosphorylation of 4EBP1 (Figure 2), Raf-1 and
ERK1/2 (Figure 6) clearly implicating PIM2 mediated activation
as well as possible cross-interactions between Notch, PI3K and
Ras/MAPK signaling molecules. Moreover, our data from
inhibition of Notch1 or PI3K signaling intermediates by
pharmacological inhibitors or dominant negative constructs
suggest the possible positive regulation of PI3K-AKT and MAPK
pathway by Notch1. Further, inhibition of PIM2 synthesis
markedly compromises M. bovis BCG ability to trigger Notch1
or COX-2 or MMP-9 expression (Figure S13). These results
clearly indicate that PIM2 is an important cell wall antigen that
contributes to M. bovis BCG ability to trigger Notch signaling in
macrophages.
Additionally, PIM2 treatment increases the surface expression
of CD44 which associates with enhanced cell-surface MMP-9
(Figure 7). CD44 is shown to associate with a proteolytic form of
MMP-9 on the surface of various tumor cells (47). Further,
disruption of CD44/MMP-9 cluster formation had resulted in
reduction of tumor invasiveness in vivo [50–51]. In this perspective,
it had been postulated that CD44/MMP-9 complex formation on
the cell surface might signify as a novel motility-enhancing signal
for tumor cells which eventually contributes their invasiveness.
Similar to results with MMP-9 expression, inhibitors of PI3K or
Notch1 activation, LY294002 (PI3K) or GSI-I abrogated PIM2
mediated expression of CD44 (Figure 7).
The PI3K or Notch1 signaling mediated activation of a given
target gene often requires recruitment of transcription factor NF-
kB [32]. Even though, the details of the PI3K mediated activation
of NF-kB are reported, molecular understanding of precise
interaction between Notch and NF-kB are not clear. However,
recent reports suggest that Notch1 in addition through cross-talk
with PI3K or MAPK, may strongly activate NF-kB (p100/p52)
expression [52]. In this perspective, PIM2 triggered significant p65
NF-kB translocation from the cytosol to the nucleus (Figure 6) in a
Notch-PI3K-MAPK dependent manner. In order to further
validate the role of Notch and NF-kB, bioinformatics analysis of
mouse COX-2 and MMP-9 promoters [53] was carried out and
analysis predicted the binding site for NF-kB between 2507 to
2519 bp and for RBP-Jk between 2717 to 2731 bp relative to
the +1 transcription start site for COX-2 promoter. In this context,
Chromatin immuno precipitation (ChIP) assays were carried out
and the data clearly suggested that PIM2 treatment increased
binding of NF-kB and RBP-Jk to COX-2 and MMP-9 promoter
(Figure S15 and data not shown). These results further support the
earlier observation that both RBP-Jk/CSL and NF-kB exerted
positive regulatory roles during PIM2 induced COX-2 and MMP-
9 expression (Figure 3G and Figure 6E–F). Our data from
experiments on PIM2 induced nuclear translocation of NF-kB
from cytosol in the presence of Notch or PI3K or MAPK
activation inhibitors clearly suggest the possibility of frequent
cross-talk between the Notch1 and PI3K-MAPK signaling
pathways. Taken together, as depicted schematically in Figure 8,
current investigation implicate PI3K and Notch1 signaling as
obligatory early proximal signaling events during PIM2 induced
COX-2 and MMP-9 expression in macrophages.
Materials and Methods
Mice and Cell Culture
C57BL/6 and C3H/HeJ mice were maintained at Central
Animal Facility, Indian Institute of Science, Bangalore, India. In
order to obtain peritoneal macrophages, peritoneal cavity of mice
were injected with thioglycollate and on fourth day of injection,
peritoneal macrophages were obtained by flushing peritoneal
cavity with 10 ml ice-cold PBS and then cultured in DMEM
(Sigma-Aldrich, USA) supplemented with L-glutamine and 10%
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with macrophages derived from mice were carried out after the
approval from the Indian Institute of Science Institutional Animal
Ethics Committee in accordance with Government of India
Guidelines as well as from Institutional Biosafety Committee of
Indian Institute of Science, Bangalore, India. RAW 264.7 mouse
macrophage cell line (Obtained from National Centre for Cell
Sciences, Pune, India) was cultivated in DMEM supplemented
with L-glutamine and 10% FBS.
Preparation of PIM2 fraction
Phosphatidyl-myo-inositol mannosides-2 (PIM2) have been
purified from M. bovis BCG 1173P2 (the Pasteur strain) envelope,
on QMA-Spherosil M (BioSepra SA, Villeneuve-la-Garenne,
France) column, as previously described [24].
Chemicals and reagents
General laboratory reagents were purchased from Sigma-
Aldrich, USA or Merck, Germany. Anti-Ser473 AKT, anti-
AKT, anti-Thr70 4EBP1, anti-4EBP1, anti-Thr180/Tyr182 p38
MAPK, anti-p38 MAPK, anti-Thr202/Tyr204 pERK1/2, anti-
ERK1/2, anti-Ser338 Raf, anti-Raf, anti-Ser536 NF-kB, anti-NF-
kB, anti-Ser32 IkBa and anti-Cleaved Notch1 antibodies were
purchased from Cell Signaling Technology, USA. Anti-Notch1
and anti-RBP-Jk antibodies were purchased from Santa Cruz
Biotechnology, USA. Anti-COX-2, anti-PCNA and HRP conju-
gated anti- mouse IgG antibodies were obtained from Calbio-
chem, USA. Anti-b-actin and anti-MMP-9 antibodies were
obtained from Sigma-Aldrich, USA. Anti-CD44 and anti-
CD16/32 (Fc blocker) antibodies were purchased from
eBioscience, USA. Cy2 or Cy5 or HRP conjugated anti-rat and
anti-rabbit IgG antibodies were purchased from Jackson Im-
munoresearch, USA. Purified PGE2 was purchased from Sigma-
Aldrich, USA.
Treatment with pharmacological inhibitors
The pharmacological inhibitors were obtained from Calbio-
chem, USA and were reconstituted in sterile DMSO and used at
following concentrations. LY294002 (50 mM), AKT Inhibitor II
(AKT I-II, 10 mM), c-secretase inhibitor I (GSI-I) (10 mM),
SB203580 (20 mM), U0126 (10 mM), SP600125 (50 mM), Manu-
mycin (20 mM), NS-398 (10 mM). DMSO at 0.1% concentration
was used as the vehicle control. In all experiments with inhibitors,
a tested concentration was used after careful titration experiments
assessing the viability of the macrophages. In experiments with
inhibitors, the macrophages were treated with a given inhibitor for
60 minutes before treatment with PIM2. We had tested different
concentrations of various inhibitors used in the current study on
their efficacy in terms of inhibition of a given kinase molecule. For
example, U0126, a known inhibitor for MEK1/2 (which activates
ERK1/2) significantly blocked M. bovis BCG triggered ERK1/2
phosphorylation (Figure S16A). Similarly, SB203580 abrogated
PIM2 triggered IkBa phosphorylation (Figure S16B).
Stable transfection of Notch Intracellular Domain (NICD)
RAW 264.7 stable cell line expressing NICD was generated by
transfection with 2 mg of plasmid pCMV-NICD using Lipofecta-
mine
TM 2000 (Invitrogen, USA). After 48 h, cells were cultured
for 10–12 days in DMEM complete medium supplemented with
400 mg /ml G418 (Calbiochem, USA) for selective growth of cells
transfected with plasmid. To use as mock control RAW 264.7 cells
stably transfected with plasmid pCMV were also generated. Stable
expression of NICD in transfected cells was confirmed by
analyzing protein level of NICD by western blotting and Hes 1
mRNA expression, a transcriptional target for Notch1 by
quantitative real time PCR.
siRNA transfections
RAW 264.7 cells were transfected with 100 nM siRNA using
Lipofectamine
TM 2000 (Invitrogen, USA) according to manufac-
turer’s instructions. Transfection efficiency has been more than
50% through all the experiments as determined by counting the
number of siGLO Lamin A/C positive cells in a microscopic field
using fluorescent microscope. 96 h post transfection, the cells were
treated with 4 mg/ml PIM2 for 12 h. Later total cell lysates were
prepared and analyzed for indicated proteins by western blotting.
siRNAs specific to Notch1, CSL/RBP-Jk, AKT, control siRNA
and siGLO Lamin A/C siRNA were obtained from Dharmacon,
USA as siGENOME
TM SMARTpool reagent, which contains a
pool of four different double-stranded RNA oligonucleotides
(siRNA). Further, in all experiments involving siRNA, the
specificity of each siRNA was assessed showing that an irrelevant
gene like Actin was not suppressed as well as the relevant one
being suppressed.
Transient transfections and luciferase assays
RAW 264.7 cells were transfected with promoter constructs of
MMP-9 (MMP-9 Luc) and Hes1 (Hes1 Luc) using Polyethyleni-
mine (PEI, Sigma-Aldrich, USA). After 36 hrs of transfection, cells
were treated with PIM2 for 12 h. Cells were harvested and lysed in
reporter lysis buffer (Promega, USA) and luciferase activity was
assayed using Luciferase assay reagent (Promega, USA). The
results were normalized for transfection efficiencies by assay of b-
galactosidase activity.
Quantitative real Time PCR
Total RNA was isolated from cells using TRIzol (Sigma-
Aldrich, USA) following to manufacturer’s protocol and then
treated with RNase free DNase (Promega, USA) to remove any
potential DNA contamination. For RT-PCR, 2 mg of total RNA
was converted into cDNA using First strand cDNA synthesis kit
(Fermentas, USA). Quantitative real time PCR was performed
with SYBR Green PCR mix from Finnzymes, Finland. All
reactions were repeated at least three times independently to
Figure 8. Model depicting PIM2 triggered signaling cascades
regulating COX-2 and MMP-9 gene expression.
doi:10.1371/journal.pone.0004911.g008
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housekeeping gene GAPDH was used as internal control. The
forward and reverse primer pairs used were as follows: GAPDH
forward 59-gagccaaacgggtcatcatct-39, GAPDH reverse 59-gaggggc-
catccacagtctt-39, COX-2 forward 59- gtatcagaaccgcattgcctc-39,
COX-2 reverse 59- cggcttccagtattgaggagaacagat-39, MMP-9
forward 59-gagctgtgcgtcttccccttc-39, MMP-9 reverse 59-ggaatgatc-
taagcccagtgc-39 Notch1 forward 59- agaatggcatggtgcccag-39,
reverse 59- tggtggagaggctgctgtgtag- 39, Notch2 forward 59-
gatggaggtgactgttccctca -39, reverse 59- cgtcttgctattcctctggcac- 39,
Notch3 forward 59- gatttcccatacccacttcgg-39, reverse 59- tgtgtaatg-
caaaaccctcagg- 39, Notch4 forward 59- gttgaagaattgatcgcagcc -39,
reverse 59- aggaaaagcggcgtctgtt- 39, Jagged1 forward 59- agaagt-
cagagttcagaggcgtcc -39, reverse 59- agtagaaggctgtcaccaagcaac- 39,
Jagged 2 forward 59- tgctgtggaggtggctatgtct-39, reverse 59-
tgtttccaccttgacctcggt- 39, Dll 1 forward 59- ggacctcagtgagaggca-
tatgg -39, reverse 59- ggcaattggctaggttgttcatg- 39, Dll 3 forward 59-
agttgcacttctcctaccgcg -39, reverse 59- acggcattcatcaggctcttc- 39,
Dll4 forward 59- gtgaactgcacatcagcgattg -39, reverse 59- gttgca-
gacgaagttgtttggg- 39, Lunatic Fringe forward 59- gacgtgtacatcgg-
caagcc -39, reverse 59- agccaatggtgcagtcatcg- 39, Manic Fringe
forward 59- ggctacatcatcgagtgcaagc -39, reverse 59- aggagacaatg-
gagggagcg- 39, Radical Fringe forward 59- ctgtgttgctgctactgccg -39,
reverse 59- ctcgtgagatccaggtacgc- 39, Kurzbanian forward 59-
ggccagcctatctgtggaaac -39, reverse 59- gtacagcagggtccttgactcg- 39,
Presinilin forward 59- gacagtggttctgggaacgatg -39, reverse 59-
cctccgggtcttcactcgttag- 39, Hes 1 forward 59- gagaggctgccaaggtttttg
-39, reverse 59- cactggaaggtgacactgcg - 39. All the primers were
purchased from Sigma Genosys, India.
Preparation of cell lysate and western blot analysis
Cells were washed with ice cold PBS and scrapped off the
culture dish and collected by centrifugation. Cell pellets were lysed
in RIPA buffer constituting 50 mM Tris-HCl, pH 7.4, 1% NP-40,
0.25% Sodium deoxycholate, 150 mM NaCl, 1 mM EDTA,
1 mM PMSF, 1 mg/ml of each aprotinin, leupeptin, pepstatin,
1m MN a 3VO4, 1 mM NaF and incubated on ice for 30 min.
Whole cell lysate was collected by centrifuging lysed cells at
13000 rpm , 10 min at 4uC. Protein concentration in each cell
lysate was determined by Bradford’s method of protein detection.
Equal protein amount from each cell lysate was subjected to SDS-
PAGE and transferred onto polyvinylidene difluoride membranes
(Millipore, USA) by the semidry Western blotting (Bio-Rad, USA)
method. Nonspecific binding was blocked with 5% nonfat dry milk
powder in TBST (20 mM Tris-HCl (pH 7.4), 137 mM NaCl, and
0.1% Tween 20) for 60 min. The blots were incubated overnight
at 4uC with primary antibodies diluted in TBST with 5% BSA.
After washing with TBST, blots were incubated with anti-rabbit or
anti-mouse IgG secondary Ab conjugated to HRP (Jackson
Immunoresearch, USA) diluted in TBST with 5% BSA for 2 h.
After further washing in TBST, the immunoblots were developed
with the ECL system (Perkin Elmer, USA) following the
manufacturer’s instructions.
Nuclear and cytosolic fractionation of peritoneal
macrophages
Peritoneal macrophages were grown in 60-mm dishes and
treated as indicated. After treatment, cells were harvested by
centrifugation at 13000 rpm for 5 min and cell pellets were
washed with phosphate buffered saline (PBS) and gently
resuspended in Buffer A (10 mM HEPES pH 7.9, 10 mM KCl,
0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT and 0.5 mM
PMSF). After incubation on ice for 15 min, cell membrane was
disrupted with 10% NP-40 and the nuclear pellets were recovered
by centrifugation 13000 rpm for 15 min at 4uC and supernatant
was used as cytosolic extract. Nuclear pellets were lysed with
Buffer C (20 mM HEPES pH7.9, 0.4 M NaCl, 1 mM EDTA,
1 mM EGTA, 1 mM DTT and 1 mM PMSF) and nuclear
extracts were collected after centrifugation at 13000 rpm for
20 min at 4uC.
Immunofluorescence
Resident mouse peritoneal macrophages were seeded on to
coverslips and treated as indicated. The cells were fixed with 3%
formaldehyde for 10 min at room temperature. Primary antibod-
ies were incubated for 1 h at room temperature following three
washes with PBS. Secondary antibodies (Cy2 conjugated anti-
rabbit IgG or Cy5 conjugated anti-rat IgG) were incubated in the
dark for 1 h at room temperature and then washed three times
with PBS. Coverslips with cells were mounted on a slide with
fluoromount G. Confocal images were taken on Zeiss LSM 510
Meta confocal laser scanning microscope using plan –Apochromat
63X /1.4 oil DIC objective and Argon/2 458, 477, 488, 514 nm
and HeNe 543 lasers. During colocalization studies, a series of
images at an interval of 0.37-mm focal planes were collected into a
z-stack to ascertain the actual colocalization. Every single layer of
z-stack was subjected to image analysis by LSM 5 image examiner
software to visualize and locate protein expression.
Flow cytometry analysis
The cells were washed with PBS and were fixed in 0.1%
formaldehyde. In order to avoid nonspecific binding, cells were
incubated with 0.5 mg Fc blocker (per 10
6 cells) for 30 minutes on
ice followed by staining with rabbit anti-mouse MMP-9. This was
followed by staining with flouro isothiocyanate (FITC) or Cy2
conjugated anti-rabbit IgG. Similarly, cells were labeled with rat
anti-mouse CD44 antibody followed by Cy5 conjugated anti-rat
IgG and were analyzed using FACScan (BD Biosciences, USA).
Dead cells were excluded from the analysis by their forward and
side-way light-scattering properties.
Inhibition of PIM2 synthesis in M. bovis BCG
M. bovis BCG Pasteur 1173P2 was grown to mid log phase in
Souton’s medium and treated with D- Mannosamine (ManN)
(Sigma Aldrich, USA) at a concentration of 5 mg/ml. Cultures
were centrifuged after 24 h and aliquots were frozen at 270uC.
Representative vials were thawed and enumerated for viable
colony forming unit on Middlebrook 7H10 agar (Difco, USA)
supplemented with OADC (oleic acid, albumin, dextrose,
catalase). For macrophage infections, single cell suspension of
bacteria were obtained after short pulses of sonication and
macrophages were infected at MOI of 1:1. Further, in experiments
with D-mannosamine, a tested concentration was chosen after
careful titration experiments assessing the viability (CFU) of M.
bovis BCG. The inhibition of PIM2 synthesis was confirmed by the
Thin-Layer chromatography of cell wall lipids as described [21].
Briefly, Bacilli were washed extensively in 0.05% Tween 80/PBS
followed by a detergent-free wash before extraction in chloroform
and methanol. The bacterial pellet was extracted twice in
chloroform/methanol (2:1 v/v) with sonication. Bacterial debris
was removed by centrifugation, and hydrophilic contaminants
were removed using a Folch wash. TLC analysis of lipids was
performed on aluminum backed plates of silica gel 60 F254
(Merck, Germany). The solvent used was CHCl3/CH3OH/
NH4OH/H2O (65:24:0.4:3.6 v/v). Visualization of resolved lipids
was achieved with a charring spray (10% CuSO4 in 8%
phosphoric acid) and heating at 110uC.
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Chromatin immunoprecipitation (ChIP) assays were carried out
following a protocol provided by Upstate Biotechnology, USA with
modifications. Peritoneal macrophageswereleftuntreated or treated
with PIM2 for 6 h as in the case of NF-kB or 12 h for CSL/RBP-Jk.
The cells were fixed with 1.42% formaldehyde for 15 min at room
temperature followed by inactivation of formaldehyde with addition
of 125 mM glycine. Chromatin extracts containing DNA fragments
with an average size of 500 bp were immunoprecipitated using anti
NF-kB for NF-kB ChIP or anti-Notch1 antibody for RBP-Jk ChIP.
Purified DNAwas analyzed byquantitative PCR byusing the SYBR
Green method (Finnzymes). Regions with the NF-kB and RBP-Jk
binding site in the mouse COX-2 promoter were amplified using
primer pairs, NF-kBf o r w a r d ,5 9-ttaaccggtagctgtgtgcgt- 39,r e v e r s e ,
59-tctccggtttcctcccagt-39; and RBP-Jk forward, 59-tcccgtgaaaa-
gagttgctga-39,r e v e r s e ,5 9-ttcatggaactaccctccgg- 39. The binding sites
in MMP-9 promoter were amplified with primers NF-kB forward,
59- gcgacaaagggtctgtttttg- 39,r e v e r s e ,5 9- tgactcagcttcctctcctgg-39;
and RBP-Jk forward, 59-atcagtcagggccgtcagac-39,r e v e r s e ,5 9-
gacccacaggaaaccacagaac- 39. 28S rRNA was used as control in the
PCR and the primers were forward, 59-ctgggtataggggcgaaagac-39
andreverse,59-ggccccaagacctctaatcat-39.Allresultswerenormalized
either by respective input values or by amplification of 28 S rRNA.
All ChIP experiments were repeated at least three times.
Statistical analysis
Levels of significance for comparison between samples were
determined by the Student t test distribution. The data in the graphs
is expressed as the mean6SEM. Graphpad Prism 3.0 software
(Graphpad software, USA) was used for all the statistical analysis.
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